The Journal of Urology
Volume 181, Issue 5 , Pages 1983-1984 , May 2009

Food for Thought: Obesity as the Major Contributing Factor for Most Urological Disorders

References 

  1. Hsing AW, Sakoda LC, Chua SC. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007;86:843S
  2. Chow WH, Gridley G, Fraumeni JF, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343:1305
  3. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455
  4. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007;178:395
  5. Cummings JM, Rodning CB. Urinary stress incontinence among obese women: review of pathophysiology therapy. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:41
  6. Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R, et al. Association of body weight with sexual function in women. Int J Impot Res. 2007;19:353
  7. Esposito K, Giugliano F, Ciotola M, De Sio M, D'Armiento M, Giugliano D. Obesity and sexual dysfunction, male and female. Int J Impot Res. 2008;20:358
  8. Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome (What are the implications for the relatively high incidence of erectile dysfunction observed in these men?). J Urol. 2006;176:1524
  9. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol. 1995;154:89
  10. Gomez P, Ruilope LM, Barrios V, Navarro J, Prieto MA, Gonzalez O, et al. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study. J Am Soc Nephrol. 2006;17(suppl.):S194
  11. Ribera MC, Pascual R, OrozcoPérezBarba C, Pedrera V, Gil V. Incidence and risk factors associated with urinary tract infection in diabetic patients with and without asymptomatic bacteriuria. Eur J Clin Microbiol Infect Dis. 2006;25:389
  12. Freedland SJ, Terris MK, Presti JC, Amling CL, Kane CJ, Trock B, et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol. 2004;172:520
  13. Rogers RG, Lebkuchner U, Kammerer-Doak DN, Thompson PK, Walters MD, Nygaard IE. Obesity and retropubic surgery for stress incontinence: is there really an increased risk of intraoperative complications?. Am J Obstet Gynecol. 2006;195:1794
  14. Chang IH, Ahn SH, Han JH, Kim TH, Kim YS, Myung SC. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration. J Urol. 2009;181:567
  15. Economic impact of obesity. http://www.obesityinamerica.org/economicimpact.html2007;
  16. Subak E, Whitcomb H, Shen J, Saxton E, Vittinghoff E, Brown JS. Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005;174:190
  17. Fairey AS, Jacobsen N-EB, Chetner MP, Mador DR, Metcalfe JB, Moore RB et al: Associations between comorbidity and overall survival and bladder cancer specific survival after radical cystectomy: results fromi the Alberta Urology Institute radical cystectomy database. Unpublished data.

PII: S0022-5347(09)00307-3

doi: 10.1016/j.juro.2009.02.013

The Journal of Urology
Volume 181, Issue 5 , Pages 1983-1984 , May 2009

Article Tools